XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity - Stock Option Activity (Details) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Apr. 15, 2020
Weighted-average assumptions        
Granted (in shares) 0      
Number of Options        
Vested and expected to vest at March 31, 2021 (in shares) 1,768,104      
Weighted Average Exercise Price Per Share        
Vested and expected to vest at March 3,1 2021 (in USD per share) $ 7.68      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures        
Vested and expected to vest at March 31, 2021, intrinsic value $ 11,572,933      
Options to purchase Common Stock        
Weighted-average assumptions        
Risk-free interest rate   1.80%    
Dividend yield (as a percent)   0.00%    
Expected volatility (as a percent)   102.00%    
Expected term   6 years    
Number of Options        
Balance outstanding at the beginning of the period (in shares) 1,860,507      
Cancelled / Forfeited (in shares) (10,770)      
Balance outstanding at the end of the period (in shares) 1,849,737      
Exercisable at the end of the period (in shares) 756,300      
Weighted Average Exercise Price Per Share        
Balance outstanding at the beginning of the period (in USD per share) $ 7.43      
Canceled / Forfeited (in USD per share) 2.55      
Balance outstanding at the end of the period (in USD per share) 7.46      
Exercisable at the end of the period (in USD per share) $ 14.61      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures        
Options outstanding, intrinsic value $ 12,125,293   $ 27,963,363  
Exercisable at the end of the period, intrinsic value $ 4,739,794      
2014 EIP        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures        
Authorized shares under the plan (in shares)       2,243,056
Number of remaining shares available for issuance (in shares) 271,216